54 related articles for article (PubMed ID: 10749123)
1. Adenovirus E1A does not induce the Ewing tumor-associated gene fusion EWS-FLI1.
Kovar H; Fallaux FJ; Pribill I; Jugovic D; Bartl S; Ambros PF; Aryee DN; Wiegant JC; Hoeben RC
Cancer Res; 2000 Mar; 60(6):1557-60. PubMed ID: 10749123
[TBL] [Abstract][Full Text] [Related]
2. An association between viral genes and human oncogenic alterations: the adenovirus E1A induces the Ewing tumor fusion transcript EWS-FLI1.
Sanchez-Prieto R; de Alava E; Palomino T; Guinea J; Fernandez V; Cebrian S; LLeonart M; Cabello P; Martin P; San Roman C; Bornstein R; Pardo J; Martinez A; Diaz-Espada F; Barrios Y; Ramon y Cajal S
Nat Med; 1999 Sep; 5(9):1076-9. PubMed ID: 10470089
[TBL] [Abstract][Full Text] [Related]
3. E1A and the Ewing tumor translocation.
Kovar H
Nat Med; 1999 Dec; 5(12):1331. PubMed ID: 10581050
[No Abstract] [Full Text] [Related]
4. EWS/ETS fusions activate telomerase in Ewing's tumors.
Takahashi A; Higashino F; Aoyagi M; Yoshida K; Itoh M; Kyo S; Ohno T; Taira T; Ariga H; Nakajima K; Hatta M; Kobayashi M; Sano H; Kohgo T; Shindoh M
Cancer Res; 2003 Dec; 63(23):8338-44. PubMed ID: 14678994
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus 5 early region 1A does not induce expression of the ewing sarcoma fusion product EWS-FLI1 in breast and ovarian cancer cell lines.
Meric F; Liao Y; Lee WP; Pollock RE; Hung MC
Clin Cancer Res; 2000 Oct; 6(10):3832-6. PubMed ID: 11051226
[TBL] [Abstract][Full Text] [Related]
6. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.
Hu-Lieskovan S; Zhang J; Wu L; Shimada H; Schofield DE; Triche TJ
Cancer Res; 2005 Jun; 65(11):4633-44. PubMed ID: 15930281
[TBL] [Abstract][Full Text] [Related]
7. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H
Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984
[TBL] [Abstract][Full Text] [Related]
8. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T
Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222
[TBL] [Abstract][Full Text] [Related]
9. Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein.
Spahn L; Siligan C; Bachmaier R; Schmid JA; Aryee DN; Kovar H
Oncogene; 2003 Oct; 22(44):6819-29. PubMed ID: 14534527
[TBL] [Abstract][Full Text] [Related]
10. The EWS protein is dispensable for Ewing tumor growth.
Kovar H; Jug G; Hattinger C; Spahn L; Aryee DN; Ambros PF; Zoubek A; Gadner H
Cancer Res; 2001 Aug; 61(16):5992-7. PubMed ID: 11507040
[TBL] [Abstract][Full Text] [Related]
11. E1A and the Ewing tumor translocation.
Melot T; Delattre O
Nat Med; 1999 Dec; 5(12):1331. PubMed ID: 10581049
[No Abstract] [Full Text] [Related]
12. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M
Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607
[TBL] [Abstract][Full Text] [Related]
13. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
14. STAT3 is activated in a subset of the Ewing sarcoma family of tumours.
Lai R; Navid F; Rodriguez-Galindo C; Liu T; Fuller CE; Ganti R; Dien J; Dalton J; Billups C; Khoury JD
J Pathol; 2006 Apr; 208(5):624-32. PubMed ID: 16463269
[TBL] [Abstract][Full Text] [Related]
15. Induction of an oncogenic fusion protein by a viral gene--a new chapter in an old story.
Kirn D; Hermiston T
Nat Med; 1999 Sep; 5(9):991-2. PubMed ID: 10470071
[No Abstract] [Full Text] [Related]
16. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
[TBL] [Abstract][Full Text] [Related]
17. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
18. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.
Tanaka K; Iwakuma T; Harimaya K; Sato H; Iwamoto Y
J Clin Invest; 1997 Jan; 99(2):239-47. PubMed ID: 9005992
[TBL] [Abstract][Full Text] [Related]
19. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
20. EWS-FLI1 inhibits TNFalpha-induced NFkappaB-dependent transcription in Ewing sarcoma cells.
Lagirand-Cantaloube J; Laud K; Lilienbaum A; Tirode F; Delattre O; Auclair C; Kryszke MH
Biochem Biophys Res Commun; 2010 Sep; 399(4):705-10. PubMed ID: 20691659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
